What are the USPSTF guidelines on cervical cancer screening?
The USPSTF recommends against screening for cervical cancer in women younger than age 21 years. The USPSTF recommends against screening for cervical cancer in women older than age 65 years who have had adequate prior screening and are not otherwise at high risk for cervical cancer.
Should you get screened for cervical cancer?
The USPSTF recommends against screening for cervical cancer with HPV testing, alone or in combination with cytology, in women younger than age 30 years. The USPSTF recommends against screening for cervical cancer in women younger than age 21 years.
How effective is cytology for cervical cancer screening?
Cytology is the foundation for long-standing cervical cancer screening recommendations, with well-established benefits and harms. The USPSTF commissioned this review to evaluate direct evidence from trials and large observational cohort studies on the comparative effectiveness of screening approaches that use hrHPV screening.
How is high-grade precancerous cervical lesion diagnosed?
Screening with cervical cytology alone, primary testing for hrHPV alone, or both at the same time (cotesting) can detect high-grade precancerous cervical lesions and cervical cancer.
How often should a woman get a Pap smear?
The USPSTF recommends screening for cervical cancer in women age 21 to 65 years with cytology (Pap smear) every 3 years or, for women age 30 to 65 years who want to lengthen the screening interval, screening with a combination of cytology and human papillomavirus (HPV) testing every 5 years.
What is a Pap smear test?
A Pap test looks for abnormal cells. An HPV test looks for infection with the types of HPV that are linked to cervical cancer. Follow these Guidelines: If you are younger than 21—You do not need screening. If you are 21 to 29— Have a Pap test alone every 3 years.
Can abnormal Pap test results lead to cervical cancer?
So, many people who get an abnormal Pap test result actually have a very low chance of developing cervical cancer. HPV/Pap cotesting is only slightly more sensitive than HPV testing, but it is less efficient because it requires two tests. And it detects a lot of minor changes that have a very low risk of turning into cancer.